1 – 10 of 41
      - show: 10
- |
- sort: year (new to old)
        Close
        
            
    
    Embed this list
<iframe src=""
              width=""
              height=""
              allowtransparency="true"
              frameborder="0">
            </iframe>
        - 2023
- 
                        Mark
        Targeting of bone morphogenetic protein complexes to heparin/heparan sulfate glycosaminoglycans in bioactive conformation
    
    - Contribution to journal › Article
 
- 2022
- 
                        Mark
        Pretreatment with heparin in patients with ST-segment elevation myocardial infarction : a report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)
    
    - Contribution to journal › Article
 
- 2021
- 
                        Mark
        Bivalirudin Versus Heparin Monotherapy in ST-Segment-Elevation Myocardial Infarction
    
    - Contribution to journal › Article
 
- 
                        Mark
        Heparin fragments induce cervical inflammation by recruiting immune cells through Toll-like receptor 4 in nonpregnant mice
    
    - Contribution to journal › Article
 
- 
                        Mark
        Binding of the human antioxidation protein α1-microglobulin (A1M) to heparin and heparan sulfate. Mapping of binding site, molecular and functional characterization, and co-localization in vivo and in vitro
    
    - Contribution to journal › Article
 
- 2020
- 
                        Mark
        Relationship between degree of heparin anticoagulation and clinical outcome in patients receiving potent P2Y12-inhibitors with no planned glycoprotein IIb/IIIa inhibitor during percutaneous coronary intervention in acute myocardial infarction : a VALIDATE-SWEDEHEART substudy
    
    - Contribution to journal › Article
 
- 
                        Mark
        Bivalirudin Versus Heparin Monotherapy in Elderly Patients With Myocardial Infarction : A Prespecified Subgroup Analysis of the VALIDATE-SWEDEHEART Trial
    
    - Contribution to journal › Article
 
- 2018
- 
                        Mark
        Pretreatment with ticagrelor may offset additional inhibition of platelet and coagulation activation with bivalirudin compared to heparin during primary percutaneous coronary intervention
    
    - Contribution to journal › Article
 
- 2017
- 
                        Mark
        Vitronectin
    (2017) p.351-360- Chapter in Book/Report/Conference proceeding › Book chapter
 
- 2015
- 
                        Mark
        Improving outcomes in patients with coronary heart disease using national registers and platelet function testing
    
    - Thesis › Doctoral thesis (compilation)
 
